What Causes Triglycerides to Be Out of Range?: A Functional-Medicine Interpretation Guide

What Your Triglyceride Number Actually Means

Triglycerides are the primary storage form of dietary fat in the body. After you eat, calories not immediately used for energy are packaged into triglyceride molecules and either stored in adipose tissue or shuttled through the bloodstream as very-low-density lipoprotein (VLDL) particles. A fasting triglyceride test measures the concentration of these lipids in your blood after an overnight fast — typically 9–12 hours — when input from a recent meal should be minimal.

The conventional reference range classifies triglycerides as follows:

The gap between "normal" and "optimal" matters. A landmark analysis of the ACCORD Lipid Trial found that participants with high triglycerides and low HDL had significantly greater cardiovascular event rates even when LDL-C was pharmacologically controlled (ACCORD Study Group, New England Journal of Medicine 2010; PMID: 20228404). Functional practitioners therefore target a fasting triglyceride level below 100 mg/dL, with the ratio of triglycerides to HDL-C ideally under 2.0 — a proxy for insulin sensitivity and small, dense LDL particle burden.

The Core Metabolic Driver: Insulin Resistance

Asking what causes triglycerides to be out of range almost always leads back to one answer: insulin resistance. When cells become desensitized to insulin signaling, the liver compensates by ramping up de novo lipogenesis — the production of new fat from carbohydrate. This hepatic fat gets packaged into VLDL particles, flooding the bloodstream with triglycerides.

A 2012 meta-analysis in Diabetologia confirmed that fasting triglycerides are a strong, independent predictor of insulin resistance even in non-diabetic individuals, with elevated triglycerides preceding measurable changes in fasting glucose by years (Abbasi et al., Diabetologia 2012; PMID: 22526603). This is why a lipid panel can function as an early-warning system for metabolic dysfunction — often before a diagnosis of prediabetes or type 2 diabetes is formally made.

The practical implication is that you cannot fully address elevated triglycerides without also investigating the markers that reveal insulin sensitivity status.

What Causes Fasting Insulin to Be Out of Range?

Fasting insulin is not included in a standard lipid panel, but it is arguably the most important companion test when triglycerides are elevated. The conventional laboratory reference for fasting insulin is typically 2–25 µIU/mL — a range so wide it captures overt diabetes but misses early insulin resistance entirely. Functional practitioners aim for a fasting insulin below 5–7 µIU/mL.

When fasting insulin is high, it usually reflects one or more of the following:

1. Excess refined carbohydrate and sugar intake — fructose in particular is processed almost exclusively by the liver and directly promotes VLDL synthesis and triglyceride secretion (Stanhope et al., Journal of Clinical Investigation 2009; PMID: 19381015).
2. Sedentary behavior — skeletal muscle is the primary site of insulin-stimulated glucose disposal; low muscle mass or physical inactivity reduces glucose clearance and amplifies hepatic lipogenesis.
3. Chronic sleep deprivation — a single week of sleep restriction impairs insulin sensitivity by 20–25% in controlled studies (Spiegel et al., Sleep 2005; PMID: 16335333).
4. Visceral adiposity — fat stored around the liver and organs releases inflammatory cytokines and free fatty acids that directly impair insulin receptor signaling.
5. Thyroid insufficiency — subclinical hypothyroidism slows lipoprotein clearance and raises both LDL and triglycerides; a TSH creeping above 2.5 µIU/mL warrants attention.

When Ones reviews a user's lab results alongside wearable data — including sleep quality and movement patterns — the AI identifies whether elevated triglycerides are likely rooted in insulin dysregulation, enabling a more targeted formula rather than a generic "heart health" stack.

What Causes Fasting Glucose to Be Out of Range?

Fasting glucose is the most widely ordered metabolic screening marker, yet its sensitivity is limited. A fasting glucose above 100 mg/dL (the ADA's prediabetes threshold) reflects a problem that has often been building for a decade. Functional practitioners consider anything above 85 mg/dL worthy of lifestyle scrutiny, particularly when paired with triglycerides above 100 mg/dL.

The liver's role is central here. When fasting glucose rises, it often indicates that the liver is failing to suppress overnight glucose production (hepatic gluconeogenesis). This same liver dysfunction — typically driven by hepatic fat accumulation — also drives elevated triglyceride secretion. The two markers therefore tend to rise in parallel, and their co-elevation is a reliable signal of non-alcoholic fatty liver disease (NAFLD), which affects an estimated 25% of the global adult population (Younossi et al., Hepatology 2016; PMID: 26707365).

Common root causes of elevated fasting glucose include:

• High dietary glycemic load
• Cortisol dysregulation (cortisol stimulates gluconeogenesis)
• Low magnesium (magnesium is required as a cofactor for over 300 enzymatic reactions, including insulin receptor phosphorylation)
• Gut microbiome imbalances that increase endotoxin load and promote systemic inflammation
• Insufficient sleep and circadian rhythm disruption

For users whose Ones assessment reveals fasting glucose trends on the higher end of the optimal range alongside elevated triglycerides, the formula may incorporate Berberine or Chromium Picolinate — both of which have clinical evidence for improving glucose metabolism — as part of a broader metabolic support strategy.

What Causes A1C to Be Out of Range?

Hemoglobin A1C (HbA1c) represents the average blood glucose level over approximately 90 days, making it a more reliable chronic marker than a single fasting glucose reading. The conventional reference considers values below 5.7% normal, 5.7–6.4% prediabetic, and ≥ 6.5% diabetic. Functionally, many practitioners aim for an A1C between 4.8% and 5.4%.

An A1C that is creeping upward — even within the "normal" range — while triglycerides are simultaneously elevated is a potent combination. It suggests that glycemic dysregulation and hepatic lipogenesis are operating together, compounding cardiovascular risk in ways that neither marker alone communicates fully.

Causes of a rising A1C beyond simple diet include:

1. Iron-deficiency anemia — low hemoglobin turnover can artificially elevate A1C; always cross-reference with ferritin and CBC when A1C seems inconsistent with glucose values.
2. Hemoglobin variants — certain genetic variants alter red blood cell lifespan, causing A1C to misrepresent true average glucose; fructosamine testing is a useful alternative.
3. Chronic stress and cortisol elevation — sustained cortisol promotes both glucose production and visceral fat accumulation, bidirectionally worsening both A1C and triglycerides.
4. Nutrient insufficiencies — low vitamin D, magnesium, and chromium are each independently associated with impaired glucose regulation.

When interpreting A1C in context of elevated triglycerides, practitioners look for convergence: if A1C, fasting glucose, fasting insulin, and triglycerides all trend in the wrong direction simultaneously, the metabolic burden is compounding, and intervention becomes more urgent. You can learn more about interpreting interconnected metabolic markers in our guide to reading your fasting insulin lab result.

What Causes LDL Particle Number to Be Out of Range?

Standard lipid panels report LDL-cholesterol (LDL-C), but the more clinically meaningful metric is LDL particle number (LDL-P), measured via NMR spectroscopy, or alternatively apolipoprotein B (ApoB), which approximates total atherogenic particle count. Research consistently shows that LDL-P predicts cardiovascular events better than LDL-C — particularly in individuals with elevated triglycerides and low HDL.

The reason: when triglycerides are elevated, LDL particles become enriched with triglycerides and depleted of cholesterol, producing more numerous but smaller, denser LDL particles. These small, dense LDL particles are more atherogenic because they penetrate the arterial wall more easily and are more susceptible to oxidation. A person can have an "acceptable" LDL-C of 110 mg/dL while harboring a dangerously elevated LDL-P — a phenomenon called "discordance" that is particularly common in metabolic syndrome.

Addressing elevated LDL particle number in the context of high triglycerides generally requires tackling the triglyceride problem first. As VLDL production falls — through dietary carbohydrate reduction, weight loss, or targeted supplementation — LDL particles shift toward larger, more buoyant patterns, and LDL-P typically improves. For a deeper look at the relationship between these markers, see our article on LDL particle size and cardiovascular risk.

Other Non-Dietary Causes of Elevated Triglycerides

While diet and insulin resistance account for the majority of cases, several other root causes deserve attention:

• Hypothyroidism: Reduced thyroid hormone slows lipoprotein lipase activity, impairing triglyceride clearance. Always check TSH, free T3, and free T4 when triglycerides are persistently elevated.
• Medications: Beta-blockers, thiazide diuretics, oral estrogens, corticosteroids, and some antipsychotics are well-documented to raise triglycerides.
• Familial hypertriglyceridemia: A genetic condition (often involving LPL or APOC3 mutations) that causes severe elevations independent of diet.
• Excessive alcohol intake: Even moderate alcohol significantly raises VLDL secretion; eliminating alcohol for 4–6 weeks before a repeat lipid panel can reveal its contribution.
• Chronic kidney disease: Impairs lipoprotein metabolism and VLDL clearance.
• Pregnancy: Physiologically expected elevation in the third trimester; not pathological in isolation.

Evidence-Based Strategies That Lower Triglycerides

The evidence base for triglyceride reduction is robust, and several interventions have documented effect sizes:

1. Reduce refined carbohydrates and added sugar — replacing 10% of calories from carbohydrate with fat or protein reduces triglycerides by an average of 10–20% in controlled trials.
2. High-dose omega-3 fatty acids (EPA + DHA) — prescription-level icosapentaenoic acid (EPA) at 4g/day reduces triglycerides by 20–30% (REDUCE-IT trial, New England Journal of Medicine 2019; PMID: 30415628). Supplemental doses of 2–3g EPA+DHA daily produce meaningful but smaller effects.
3. Aerobic exercise — 150–300 minutes per week of moderate-intensity aerobic activity consistently lowers fasting triglycerides by improving insulin sensitivity and VLDL clearance.
4. Weight loss — even modest reductions (5–10% of body weight) reduce hepatic fat and VLDL output substantially.
5. Niacin (nicotinic acid) — historically effective at reducing triglycerides by 20–50% and raising HDL, though clinical outcomes trials have not shown cardiovascular benefit when added to statins.
6. Berberine — emerging evidence shows comparable triglyceride-lowering effects to statins in some metabolic contexts, likely via AMPK activation and improved insulin signaling.

What This Means for Your Formula

At Ones, elevated triglycerides are never interpreted in isolation. The AI practitioner cross-references triglyceride levels against fasting glucose trends (if available from wearable or lab data), dietary patterns from health history intake, and inflammatory markers to determine the most likely upstream driver.

For users whose panel shows elevated triglycerides with a metabolic or insulin-resistance pattern, relevant ingredients from Ones' catalog may include:

• Omega-3 (EPA + DHA): Dosed at clinically meaningful levels (targeting 2–3g combined EPA+DHA daily), directly reducing hepatic VLDL secretion and supporting LDL particle composition. This aligns with the mechanism validated in the REDUCE-IT trial (PMID: 30415628).
• Berberine: Activates AMP-activated protein kinase (AMPK), improving hepatic glucose and lipid metabolism simultaneously — addressing both the insulin resistance root cause and the downstream triglyceride elevation.
• Ones Heart Support blend: A proprietary combination designed to support healthy lipid metabolism and cardiovascular function, formulated to complement individual actives rather than replace them.

Because Ones formulas come in 6 or 9-capsule daily plans calibrated to the full picture of your findings — not a one-size-fits-all stack — ingredient selection and dosing reflect your specific metabolic pattern rather than a generic "triglyceride formula." Users can also explore how omega-3 dosing affects triglyceride levels for a closer look at the evidence behind EPA and DHA targets.

Key Takeaways

• Triglycerides above 100 mg/dL deserve functional-medicine attention even when conventional labs read "normal" — the optimal range is 80–100 mg/dL.
• Insulin resistance is the primary metabolic driver of elevated fasting triglycerides; fasting insulin, fasting glucose, and A1C are essential companion markers.
• Elevated triglycerides create a pattern of small, dense LDL particles that inflates cardiovascular risk even when LDL-cholesterol appears acceptable — LDL particle number (LDL-P) or ApoB provides the fuller picture.
• Non-dietary causes — including hypothyroidism, certain medications, and alcohol — must be ruled out before attributing elevated triglycerides to diet alone.
• High-dose EPA + DHA (2–4g/day) is the most robustly evidence-supported supplement intervention, with the REDUCE-IT trial demonstrating a 25% reduction in major cardiovascular events at 4g/day of EPA.
• Ones interprets triglyceride data alongside your full lab and lifestyle profile to identify the most likely upstream cause and build a targeted, capsule-efficient formula — not a generic lipid support stack.